Downing Llp investment portfolio

Invizius develops second‑generation complement‑system therapeutics to treat autoimmune and inflammatory disorders and to improve patient outcomes in dialysis and other extracorporeal therapies.

Memgraph delivers an in‑memory graph database platform optimized for real‑time analytics and AI workloads, offering features such as GraphRAG, AI memory, and high‑performance query processing. Its primary customers are enterprises seeking fast, connected data reasoning for applications like fraud detection, knowledge graphs, and AI‑driven context management.